Fighting Antibiotic Resistance With Whole Genome Sequencing
FDA Direct: эти 9 препаратов получили национальные приоритетные ваучеры
FDA Direct: Catching Up on Agency Reforms
Medical Device Quality Management System Regulation Risk Management
Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults
Medical Device Quality Management System Regulation Design and Development
FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)
FDA Expert Panel on Testosterone Replacement Therapy for Men
GCP & Pharmacovigilance Compliance Symposium | D2S06 – Panel Discussion
FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)
November 13, 2025: Pediatric Advisory Committee Meeting (PAC)
Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel
Public Meeting: Reauthorization of the Biosimilar User Fee Act
Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025
Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy
Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...
FDA Direct: FDA Awards Six National Priority Vouchers
GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct
Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates